最新更新 :
19/11/2024
研究小組 - College of Pharmacy and Pharmaceutical Sciences, The University of Toledo   PDF  
美国
大學
College of Pharmacy and Pharmaceutical Sciences, The University of Toledo
Tolède
引用文献   引用文献   (21)  
1
Intravenous Physical Compatibility of Heparin Sodium and Furosemide.
Maktabi B, Howard MS, Baki G, Churchwell MD (Mariann.Churchwell@utoledo.edu)
Int J Pharm Compound - 2022 - ;26,6:522-526
2
The Physical Compatibility of Clinically Used Concentrations of Diltiazem Hydrochloride With Heparin Sodium.
Dobson, S.R, Mauro, V.F, Boddu, S.H.S, Churchwell, M.D. (vmauro@utoledo.edu)
J Pharm Technol - 2020 - ; 36, 4: 126-129.
3
Physical compatibility of levetiracetam injection with heparin, dobutamine, and dopamine.
Cruz K, Chrchwell M, Mauro V, Boddu. (vmauro@utnet.utoledo.edu)
Am J Health-Syst Pharm - 2018 - ;75;8:510-512
4
Physical compatibility of milrinone with levofloxacin and ceftriaxone injection.
Ross A, Boddu S, Mauro V, Churchwell M. ()
EJHP - 2018 - ;75,14:1010-1012
5
Physical compatibility of valproate sodium injection with dobutamine and dopamine.
Frank M.I, Boddu S.H.S, . Mauro V.F,. Churchwell M.D. (vmauro@utnet.utoledo.edu)
Am J Health-Syst Pharm - 2017 - ; 74, 5: 280-281.
6
Compatibility, Stability, and Efficacy of Vancomycin Combined With Gentamicin or Ethanol in Sodium Citrate as a Catheter Lock Solution.
Wei Y, WonJoon Yang J, Boddu S, Jung R, Churchwell M. (mariann.churchwell@utoledo.edu)
Hosp Pharm - 2017 - ;52,10:685-690
7
Compatibility of conivaptan injection with select cardiovascular medications.
Mauro V.F, Howard M.S, Boddu S.H.S, Churchwell M.D. (vmauro@utnet.utoledo.edu)
Am J Health-Syst Pharm - 2014 - ; 71:1534-1535
8
Compatibility of argatroban injection with select antiarrhythmic drugs
Jakimczuk P.J, Churchwell M.D, Howard M.S, Mauro V.F, Alexander K.S, Boddu S.H.S. ()
Am J Health-Syst Pharm - 2014 - 2014; 71: 1831-1832.
9
Physical compatibility of sodium citrate with alcohol and cefepime.
Csaba M, Boddu,S.H.S , Churchwell M.D. ()
Am J Health-Syst Pharm - 2013 - ; 70: 932-937
10
Physical compatibility of 4% sodium citrate with 23.4% sodium chloride, fluconazole, and micafungin.
Bryan Dotson B, Churchwell MD. ()
Am J Health-Syst Pharm - 2011 - ; 68:377-378.
11
Physical compatibility of 4% sodium citrate with selected antimicrobial agents.
Dotson B, Lynn S, Savakis K, Churchwell MD. ()
Am J Health-Syst Pharm - 2010 - ; 67: 1195-1198.
12
Physical compatibility of metoprolol tartrate injection with selected cardiovascular agents
Newland A.M, Mauro V.F, Alexander K.S. ()
Am J Health-Syst Pharm - 2009 - ; 66: 986-987.
13
Stability of An Extemporaneously Compounded Propylthiouracil Suspension
Alexander KS, Mitra P. (kalexan@utnet. utoledo.edu)
Int J Pharm Compound - 2005 - ; 9, 1: 82-86.
14
Compatibility of argatroban with selected cardiovascular agents.
Honisko ME, Fink JM, Militello MA, Mauro VF, Alexander KS. ()
Am J Health-Syst Pharm - 2004 - ; 61: 2415-2418.
15
Stability of magnesium sulfate in 0.9% sodium chloride and lactated Ringers solutions.
Sarver J.G, Pryka R, Alexander K.S, Weinstein L, Erhardt P.W. ()
Int J Pharm Compound - 1998 - ; 2, 5: 385-388.
16
Stability of an extemporaneously formulated levothyroxine sodium syrup compounded from commercial tablets.
Alexander KS, Kothapalli MR, Dollimor D. ()
Int J Pharm Compound - 1997 - : 60-63.
17
The formulation development and stability of metronidazole suspension.
Alexander KS, Vangala SSKS, Dollimore D. ()
Int J Pharm Compound - 1997 - ; 1: 200-205.
18
The Formulation Development and Stability of Spironolactone Suspension
Alexander KS, Sundar S, White DB, Dollimore D. ()
Int J Pharm Compound - 1997 - ; 1, 3: 195-199.
19
Stability of hydralazine hydrochloride syrup compounded from tablets.
Alexander KS, Pudipeddi M, Parker GA. ()
Am J Hosp Pharm - 1993 - ; 50: 683-686.
20
Incompatibility of ketorolac tromethamine with selected postoperative drugs.
Knapp AJ, Mauro VF, Alexander KS. ()
Am J Hosp Pharm - 1992 - ; 49: 2960-2962.
21

药品清单   分子研究   (47)  

  Mentions Légales